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Increased flow resistance is responsible for the elevated intraoc-
ular pressure characteristic of glaucoma, but the cause of this
resistance increase is not known. We tested the hypothesis that
altered biomechanical behavior of Schlemm’s canal (SC) cells con-
tributes to this dysfunction. We used atomic force microscopy,
optical magnetic twisting cytometry, and a unique cell perfusion
apparatus to examine cultured endothelial cells isolated from
the inner wall of SC of healthy and glaucomatous human eyes.
Here we establish the existence of a reduced tendency for pore
formation in the glaucomatous SC cell—likely accounting for in-
creased outflow resistance—that positively correlates with ele-
vated subcortical cell stiffness, along with an enhanced sensitivity
to the mechanical microenvironment including altered expression
of several key genes, particularly connective tissue growth factor.
Rather than being seen as a simple mechanical barrier to filtration,
the endothelium of SC is seen instead as a dynamic material whose
response to mechanical strain leads to pore formation and thereby
modulates the resistance to aqueous humor outflow. In the glau-
comatous eye, this process becomes impaired. Together, these
observations support the idea of SC cell stiffness—and its bio-
mechanical effects on pore formation—as a therapeutic target
in glaucoma.
cell mechanics | primary open-angle glaucoma | modulus | cytoskeleton
Aqueous humor flows across the inner wall endothelium ofSchlemm’s canal (SC) and generates a transendothelial
pressure gradient from the cellular base to the cellular apex.
From a biomechanical perspective, the direction of this gradient
is remarkable considering that the endothelium of the systemic
vasculature experiences a pressure gradient in precisely the op-
posite direction. In the healthy eye, this basal-to-apical trans-
cellular pressure gradient is of sufficient magnitude to partially
separate the SC cell from its supporting basement membrane,
inflate dome-shaped structures known as giant vacuoles, and
generate cellular mechanical strains exceeding 50% (Fig. 1) (1).
The formation of giant vacuoles leads to substantial thinning
of the SC endothelial cell and is thought to be associated with
formation of pores that provide an outflow pathway across the
SC endothelium (2). Although reported dysfunction of the pore
formation process might be expected to affect outflow resistance
and elevate intraocular pressure (IOP) (3, 4), mechanisms for
such dysfunction have never before been established, in large
part because SC cells from healthy eyes are so difficult to isolate
technically, but also because isolated SC cells from the glau-
comatous eye are a resource that has been exceedingly scarce.
Here for the first time to our knowledge we show that the pro-
cess of pore formation differs substantially between cells from
the healthy versus the glaucomatous human eye and show, fur-
ther, that this difference depends upon cytoskeletal stiffness that
is altered in the glaucomatous SC cell, likely owing to altered
substrate sensitivity and gene expression in these cells. Specifi-
cally, stiffer glaucomatous cells impede pore formation and thereby
elevate IOP.
Results
Pore Formation in SC Cells Is Altered in Glaucomatous Cell Strains. To
examine pore formation in SC cells, we used an in vitro mono-
layer perfusion system to mimic the biomechanical and filtration
environment of SC endothelium in vivo (5). As described pre-
viously, SC cells were isolated from normal and glaucomatous
human donors and extensively characterized (Materials and
Methods) (6, 7). When perfused in a basal-to-apical direction
pores formed in SC cell monolayers, with pores passing trans-
cellularly through individual SC cells or paracellularly between
neighboring SC cells, consistent with the two pore types observed
along the SC endothelium in situ (Fig. 2A) (8). The density of
pores (pores per cell area) increased significantly with perfusion
pressure (P < 3 × 10−5; Fig. 2B), and porosity (pore area per cell
area) showed a similar dependence upon pressure (P < 0.003;
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online supplement). The increase in pore density with perfu-
sion pressure was observed for both transcellular and para-
cellular pores (P < 0.005; SI Text). Apical-to-basal perfusion
of these monolayers showed no such dependence of pore density
(Fig. 2B) or porosity (SI Text) on perfusion pressure, consistent
with previous studies showing rectified flow across this endo-
thelium and its role as part of the blood–aqueous barrier (9).
Compared with the pore density measured in normal SC cell
strains perfused in a basal-to-apical direction at 6 mmHg, pore
density in glaucomatous SC cell strains was markedly reduced;
pore density in glaucomatous cells was threefold smaller and the
difference was highly statistically significant (P < 2 × 10−4;
Fig. 2C). Pore density seen in glaucomatous SC cell strains
perfused at 6 mmHg was comparable to unperfused normal
controls (Fig. 2 B and C). Porosity was similarly reduced in
glaucomatous SC cells compared with SC cells from normal
eyes (P < 0.04; SI Text) and was attributable to a reduction in
transcellular and paracellular pores, although neither alone
achieved statistical significance.
Glaucomatous SC Cells Demonstrate Elevated Subcortical Stiffness.
We reasoned that it would be more difficult for a pore to form in
stiffer SC cells. To investigate this possibility, we measured the
stiffness of SC cells isolated from normal and glaucomatous
human donors (Materials and Methods) using atomic force mi-
croscopy (AFM) using both sharp tips (20-nm tip radius) and
rounded tips (4.5 μm and 10 μm) (10). In other cellular systems,
AFM measurements using a sharp tip characterize the cell cor-
tex, whereas larger, spherical tips probe the subcortical cyto-
skeleton (10). Here we use the term “cortex” to refer to the
actin-dense region of the cell lying immediately beneath the
plasma membrane, and the term “subcortical cytoskeleton” to
refer to the internal cytoskeleton underlying the cortex (11). For
all tip geometries, elastic moduli were found to be similar be-
tween nuclear and peripheral regions of the cell, and there was
no systematic variation between Young’s modulus and donor age
(SI Text). Cell stiffness measured with sharp tips was 10-fold
higher than that measured with the larger, spherical tips (Fig.
3B), consistent with the prominent actin-rich cell cortex found
in SC cells and other endothelia (Fig. 3A).
Measured with a sharp AFM tip, we found no difference in
stiffness between normal versus glaucomatous SC cells (P > 0.85;
Fig. 3B). Cortex thickness as measured by structured illumina-
tion microscopy was similar between normal (400 ± 20 nm, n = 3
cell strains) and glaucomatous SC cells (380 ± 60 nm, n = 2).
However, when measured with the larger, spherical AFM tips,
we found systematic differences in stiffness between glaucoma-
tous SC versus normal SC cells (Fig. 3 B and C). With a 4.5-μm
tip, the modulus of glaucomatous SC cells was 1.47 ± 0.29 kPa
(n = 5 cell strains; m = 128 measurements), whereas that of
normal SC cells was measured as 1.01 ± 0.12 kPa (n = 6; m =
104) (P < 0.12). Using a 10-μm tip, the modulus of glaucomatous
SC cells was 1.24 ± 0.11 kPa (n = 5; m = 120), whereas that of
normal SC cells was 0.79 ± 0.10 kPa (n = 6; m = 153) (P < 0.02).
Relative to the normal SC cells, glaucomatous SC cells revealed
substantially elevated subcortical stiffness. Both cortical and
subcortical SC cell stiffness were greatly reduced by latrunculin-A,
consistent with an important role for actin in determining
stiffness (Fig. 3A); however, there was no difference in the rel-
ative decrease in cell stiffness following latrunculin between
normal and glaucomatous SC cells (SI Text), suggesting that
perhaps another constituent of the subcortical cytoskeleton [e.g.,
intermediate filaments (11)] may be altered in glaucomatous
SC cells.
For two normal and three glaucomatous SC cell strains in
which both cell stiffness and pore density were measured we
examined the relationship between these parameters. Subcortical
stiffness (10-μm spherical tip) was related inversely to pore
density (P < 0.002; Fig. 3D) and porosity (P < 0.012; SI Text). A
relationship was apparent between subcortical stiffness and pore
density for both pore subtypes; however, subcortical stiffness
showed a more significant correlation with transcellular pore
density (P < 0.02) compared with paracellular pore density (P <
0.07) (SI Text). These data do not establish causality but do
strongly support the idea that increased subcortical cell stiffness
and decreased pore formation go hand in hand.
On Increasingly Stiffer Gels, Both Normal and Glaucomatous SC Cells
Stiffen.We asked next what might cause this stiffness difference.
One possibility is mechanotransduction of the mechanical
properties of the SC cell microenvironment (12, 13). We thus
investigated how substrate stiffness might influence SC cell
Fig. 1. Aqueous humor flow pathway. (Left) Sche-
matic of anterior segment of eye showing the di-
rection of aqueous humor flow in red. (Center)
Enlargement of the iris-cornea angle (boxed region
in left panel) to show the conventional outflow
pathway. (Right) Transmission electron micrograph
of endothelial cells forming the inner wall of SC;
aqueous humor crosses the endothelium through
pores to enter the lumen of SC. V, giant vacuoles.
C is reproduced with permission from ref. 41.
Fig. 2. Pore density in perfused SC monolayers. (A) Representative image of
transcellular and paracellular pores in normal (SC52) and glaucomatous SC
(SC62g) cells. (B) Pore density increases in monolayers formed from three
nonglaucomatous SC cell strains with transcellular (basal-to-apical) pressure
drop; in one SC cell strain (SC67) perfused in the apical-to-basal direction
(AB), pore densities are similar to unperfused controls at 0 mmHg. (C) Pore
density is reduced in glaucomatous compared with normal SC cells following
perfusion at 6 mmHg in the basal-to-apical direction. Bars are SEM.
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stiffness and gene expression. Because of the need to examine
a large number of cells on substrates of a variety of stiffnesses, we
used optical magnetic twisting cytometry (OMTC) (Materials and
Methods) to study SC cells isolated from normal and glaucom-
atous human donors (Materials and Methods).
Grown on rigid substrates, we found no difference in stiffness
between normal and glaucomatous SC cells strains (SI Text), and,
as expected, these results were consistent with the AFM findings
using a sharp tip described above (11, 14). We also examined
how SC cells grown on rigid substrates responded to drugs with
known effects on outflow resistance. Similar to our finding pre-
viously reported for normal SC cells (15), we found in glau-
comatous SC cells that every agent that we examined that
decreased outflow resistance also decreased cell stiffness, and
every agent that increased outflow resistance also increased cell
stiffness (SI Text).
We then examined the influence of substrate stiffness on
the cells. The physiological substrate of the SC cell is the tra-
becular meshwork, and its compressive Young’s modulus has
been reported to be substantially increased in glaucoma (16).
Normal and glaucomatous SC cells were cultured on collagen-
coated polyacrylamide gels of tunable stiffness (Materials and
Methods) with Young’s moduli ranging from 1.1 kPa to 34.4 kPa,
the former mimicking normal trabecular meshwork and the lat-
ter mimicking glaucomatous trabecular meshwork (albeit not
modeling the complex geometry of the basement membrane and
juxtacanalicular connective tissue that underlie the SC cells).
With increasing gel stiffness SC cells exhibited more prom-
inent actin stress fibers and vinculin-containing focal adhesions
(compare Fig. 4 A and B), suggestive of increased cytoskeletal
contractility and/or elevated cell stiffness. OMTC measurements
showed that normal SC cells stiffened in response to increased
substrate stiffness (P = 10−6; Fig. 4 C and D) and were 131%
stiffer when cultured on the stiffest gel compared with the softest
gel. Glaucomatous SC cells showed a much greater stiffening
response (P = 0.011 comparing normal versus glaucoma), in-
creasing by 371% over the same range of substrate stiffness (Fig.
4 E and F). Thus, similar to other endothelial cells, SC endo-
thelial cells stiffen in response to increasing substrate stiffness.
Compared with the healthy SC cell, the glaucomatous SC cell
exhibits a strikingly enhanced stiffening response.
Expression of Glaucoma-Related Genes Is Dependent upon Substrate
Stiffness and Exaggerated in Glaucomatous Cell Strains. In endo-
thelial cells and fibroblasts, substrate stiffness is known to modulate
gene expression (17–19). Using real-time quantitative PCR as a
function of substrate stiffness in normal and glaucomatous SC
cells (Materials and Methods), we examined the expression levels
of 13 genes (Table 1) previously linked to mechanosensing, glau-
coma, ECM remodeling, or TGF-β2/connective tissue growth
factor (CTGF) signaling.
The mRNA expression of Col1a1 was up-regulated by up to
20-fold with increasing substrate stiffness for both normal and
glaucomatous cells (P < 10−9), with no significant difference
between normal and glaucomatous cells (P > 0.4) (Fig. 5A) (see
Materials and Methods for statistical treatment). Significant
Fig. 3. Young’s modulus for normal and glaucomatous SC cells as measured
by AFM. (A) Structured illumination microscopy images of normal and
glaucomatous SC cells labeled with actin filament marker (42) rAV-LifeAct-
TagGFP2 before and after application of latrunculin-A. Thick arrows, cortex;
thin arrows, stress fibers. (B) Median and SEs of the modulus of six normal
(blue) and five glaucomatous (red) nonconfluent SC cell strains as measured
with three different AFM tips. Modulus is determined from force-deformation
curves using a modified Hertzian analysis (10); *P = 0.117, **P = 0.017. (C)
Box and whisker plot (43) of individual AFM measurements of cell modulus
using a 10-μm tip for each of the six normal and five glaucomatous SC cell
strains examined. (D) There is a significant correlation (dark line) between
pore density and the modulus of the subcortical cytoskeleton, as measured
by AFM using a 10-μm spherical tip. Bars represent SEM on pore density and
modulus. Light curves in D represent 95% confident intervals on the slope of
the GLM linear regression.
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Fig. 4. Influence of substrate stiffness on the biomechanical properties of
SC cells. As the substrate stiffness increases, the stiffness of SC cells increases
by different amounts in a donor- and disease-dependent manner. (A and B)
Fluorescent micrographs of normal SC cells labeled for f-actin (red), vinculin
(green), and DNA (blue) at two levels of substrate stiffness; black dots
are 4.5-μm magnetic beads used for OMTC. (Scale bars: 50 μm.) (C and D)
Cell stiffness index (g) of normal (blue) and glaucomatous (red) SC cells as
measured by OMTC and expressed for individual cell strains (numbers above
figure indicate cell strain) (C) or averages over all cell strains (D). (E and F)
Stiffness index normalized by the value at the lowest substrate stiffness,
expressed for individual cell strains (E) or averages over all cell strains (F).
Median ± SEM with n > 600 beads for C and E; mean ± SEM with n = 5 cell
strains each for D and F. Note that because the embedding depth of the
beads in the cells is not known, an index of cell stiffness, g, is presented
rather than an absolute value (44).
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increases with increasing substrate stiffness were also seen for
SPARC (P < 10−6), TGM2 (P < 10−4), ACTA2 (P < 10−5),MMP2
(P < 10−4), PAI1 (P < 0.005), BMP4 (P < 10−4), andGREM1 (P <
10−5) (Fig. 5 B, C, H– J, L, and M). Marginally statistically
significant increases (0.01 < overall P < 0.05) in TPM1 and
TGFβ2 were observed with increasing substrate stiffness (Fig. 5
D and F). These results indicate that normal and glaucomatous
SC cells share some common molecular responses to elevated
substrate stiffness.
We also identified three genes that were differentially modu-
lated by substrate stiffness in glaucomatous compared with normal
SC cells. PTGS2 had a marginally significant negative association
with substrate stiffness in glaucomatous cells (overall P < 0.03)
but not in normal cells (Fig. 5K). Importantly, CTGF and DCN
were more strongly up-regulated by elevated substrate stiffness
in glaucomatous SC cells (P < 0.05, P < 10−3, respectively) than
in normals (Fig. 5 E and G). Of note, the absolute increase in
CTGF gene expression in glaucomatous cell strains, compared
with normals (P < 0.05), was the highest of all of the genes
investigated (Fig. 5N). Other genes with higher expression in
glaucomatous SC cells included TGF-β2 (P < 0.05) and PAI1
(P < 0.01). Genes with lower expression in glaucomatous SC
cells included DCN (P < 0.05) and BMP4 (P < 0.01).
Together, these data demonstrate that SC cells modulate their
gene expression in tandem with substrate stiffness and that glau-
comatous SC cells have altered substrate sensitivity that affects
key genes, particularly CTGF and DCN. In a mouse model of
glaucoma, CTGF has been associated with increased stress fi-
ber formation, IOP elevation, and glaucomatous optic neu-
ropathy (20). Here we establish a link between the expression
of these same genes and changes of substrate stiffness.
Discussion
The cause of the elevated pressure and increased outflow re-
sistance characteristic of glaucoma is unknown despite being
a topic of investigation for over 140 y (21). Recent studies have
focused on the role of decreased extracellular matrix perme-
ability (22) or increased extracellular matrix stiffness (16) in the
glaucomatous process. Our studies here suggest that the cells of
the inner wall of SC may play a fundamental role in generating
increased outflow resistance in the diseased eye. The density
of pores in glaucomatous eyes is lower than in normal eyes
(3, 4). Pores in the inner wall endothelium of SC are thought
to modulate aqueous outflow resistance through a hydrodynamic
interaction with the flow of aqueous humor passing through the
trabecular meshwork (23, 24). Thus, decreased pore density is
expected to increase the resistance to outflow of aqueous humor
from the eye and thereby increase IOP, a characteristic of many
cases of glaucoma. Moreover, in the glaucomatous eye the ul-
trastructure and material properties of the trabecular meshwork
that supports the SC cell are altered (16, 25, 26). Because SC
cells from glaucomatous human eyes comprise a scarce experi-
mental resource, an innate limitation of this study is that the
differences reported between normal versus glaucomatous SC
cells may be inherent to the disease process itself or may arise
instead from chronic exposure to drugs used to treat the disease.
Although we cannot distinguish between these possibilities, we
do establish that these glaucomatous SC cells exhibit elevated
subcortical cell stiffness, enhanced sensitivity to the mechanical
Table 1. Genes investigated and the proteins they code for
Gene Protein
ACTA2 Alpha smooth muscle actin (SMA)
Col1A1 α-1 type I collagen
CTGF Connective tissue growth factor
DCN Decorin
MMP2 Matrix metalloproteinase-2
PAI1 Plasminogen activator inhibitor-1
PTGS2 Prostaglandin-endoperoxide synthase 2 (COX-2)
SPARC Secreted protein acidic and rich in cysteine
TGF-β2 Transforming growth factor- β2
TGM2 Tissue transglutaminase
TPM1 Tropomyosin α-1 chain
BMP4 Bone morphogenetic protein 4
GREM1 Gremlin 1
Fig. 5. Increases in substrate stiffness modulated SC
cell gene expression. (A–M) The increases in substrate
stiffness expression levels in normal or glaucomatous
cell strains relative to that on the softest gel of that
cell strain. Increased substrate stiffness led to in-
creased expression in all genes except PTGS2 that
showed constant or decreased expression. (N) The
expression levels of 13 genes averaged across sub-
strate stiffness and across donors were compared
between normal and glaucomatous cell strains, nor-
malized to the averaged expression level in the normal
cells on the softest gel. Statistically significant differ-
ences between normal and glaucomatous cells in-
dicated by *P < 0.05 and **P < 0.01. Mean ± SEM
with n = 5 for A–M; mean ± SEM with n = 25 for N.
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microenvironment, and altered gene expression, notably CTGF,
which has been shown to lead to ocular hypertension and glau-
comatous optic neuropathy in mice (20). Furthermore, we have
demonstrated that these altered material properties of the
glaucomatous SC cells render them less able to form pores and
thus presumably lead to increased IOP.
To lower IOP in glaucoma, two classes of new drugs are cur-
rently in clinical trials—Rho kinase inhibitors and actin depoly-
merizers (27, 28)—both of which lower outflow resistance (29,
30). The exact site of action in the conventional outflow tract of
these drugs in lowering IOP in glaucoma is unknown, but it is
interesting to note that both classes cause cell stiffness to de-
crease (15). We demonstrate here that both normal and glau-
comatous SC cells alter their stiffness when treated with drugs
that alter outflow resistance. These findings emphasize the im-
portance of cell stiffness and the contractile state to the modu-
lation of aqueous humor outflow resistance and control of IOP.
The mechanosensitivity of SC cells thus represents an interesting
therapeutic target for restoring the function of the conventional
outflow pathway. Specifically, targeting SC cell stiffness is likely
to provide an efficacious therapeutic approach to lower IOP for
glaucoma therapy, with minimal off-target effects.
Materials and Methods
In the past, the comparison between normal and glaucomatous tissues and
cells has been hindered by the lack of fresh human donor eyes. Our work
included SC cells from nine normal and four glaucomatous donors, repre-
senting the largest collection of such samples to date (Table 2).
SC Cell Isolation and Culture. Human SC cells were isolated from cadaveric
ocular tissue provided by Midwest Eye Bank, National Disease Research In-
terchange, or Life Legacy within 36 h of death with enucleation occurring
less than 6 h after death. Isolation of cells from donor eye tissue was done
according to techniques developed and optimized previously (6). Before
use in experiments, all SC cell strains were characterized using three in-
clusion criteria: the expression of vascular endothelial cadherin, a net trans-
endothelial electrical resistance of 10 ohms·cm2 or greater, and the lack of
myocilin induction by dexamethasone as described previously (7). We ex-
amined the change in cell stiffness with cell passaging and found no change
through passage 6 (SI Text). A total of nine different cell strains isolated
from nine donor eyes without a history of eye disease and five different cell
strains isolated from four donors having a history of glaucoma were used
in the present study (Table 2). For determination of ocular hypertension/
glaucoma for eye donors, we relied on a combination of the following in-
formation provided to us by eye/tissue banks and/or analyses that were
conducted on donor eyes once they were received in our laboratory: docu-
mentation of ocular hypertension/glaucoma history, presence of glaucoma
eye drops on patient medication list, abnormally low outflow facility mea-
surement of whole globes (<0.1 μL·min−1·mmHg−1 measured at time of re-
ceipt in the laboratory), and/or abnormally low axon counts (<500,000 axons
per optic nerve).
SC Monolayer Perfusion and Pore Counting. SC monolayers were perfused
and pore counts made following previously described methods (5, 8). Briefly,
SC cells of passages 3–5 were seeded at confluence (4.5 × 104 cells/cm2) on
track-etched filters and cultured for 2 d. SC cell layers were perfused in the
basal-to-apical direction at 2 or 6 mmHg for 30 min with DMEM + 25 mM
Hepes. Cell layers were then immersed in fixative while continuing perfusion
with medium for an additional 30 min. For controls, cell layers were either
not perfused and immersion-fixed at 0 mmHg or perfused in the opposite
(apical-to-basal) direction at 6 mmHg followed by immersion in fixative. SC
cell layers were processed and examined by scanning electron microscopy,
pores were analyzed in 12 randomly selected regions (5,500 μm2 each) per
cell layer, and pore density and porosity (percentage area covered by pores)
determined. Details are given in SI Text.
AFM. AFM measurements were made on subconfluent normal or glaucom-
atous SC cells at passage 4 or 5 with sharp pyramidal tips or spherical tips of
diameter 4.5 or 10 μm using a Bioscope Catalyst atomic force microscope
(Bruker). Young’s modulus was determined using a modified Hertzian analysis
(10). Studies with latrunculin-A used a concentration of 1 μM, with cells trea-
ted for 30 min.
Cortex and Cell Imaging. For imaging, SC cells were transduced with an
adenovirus delivering an actin filament marker, rAV-LifeAct-TagGFP2 (ibidi).
After 48 h of transduction, cells were washed with buffered saline. Cells were
then imaged with a Nikon-structured illumination microscope before and after
latrunculin-A treatment. Cortex thickness measurements were made from in-
tensity profilesdefining thickness as fullwidthathalf-maximum intensity. Cortex
thickness was measured on roughly 10–25 cells of each cell strain and then
averaged over the cell strains for three normal and two glaucomatous strains.
OMTC. Detailed descriptions and validations of OMTC have been given
elsewhere (15, 31–33). Briefly, to probe the cortical cytoskeletal stiffness,
ferrimagnetic beads (4.5-μm diameter) were coated with poly-L-lysine (PLL).
The beads were allowed to attach to cells for 25–50 min. They were then
magnetized with a strong magnetic pulse in the horizontal direction and
twisted with a much weaker magnetic field in the vertical direction. This
vertical field, which oscillates at 0.77 Hz, imposed a sinusoidal torque on
each bead. The torque was automatically adjusted to achieve a median bead
motion of about 60 nm. The bead motion was quantified by image analysis.
The ratio of magnetic torque to bead motion defines the apparent stiffness
(g*) measured by each bead (34). g* is a complex number and we report the
modulus g = jg*j, which has units of pascals per nanometer.
Fabrication of Substrates with Varied Stiffness and Testing Procedure. Pub-
lished protocols were followed tomake polyacrylamide gels composed of 8%
(wt/vol) acrylamide, 3% (wt/vol) (3-acrylamidepropyl) trimethylammonium
chloride (API), and a variable percentage of bisacrylamide (0.04, 0.1, 0.2, 0.5,
and 1.3%; wt/vol) (18, 35–37). These API gels were positively charged and
electrostatically absorb ECM proteins, including collagen 1 (36). Previous work
confirmed the absorption of fibronectin and collagen to be independent of
gel stiffness (38). Gels were cast between two glass plates to achieve a final
thickness of about 0.8 mm. Disks 5 mm in diameter were punched out of gel
sheets using surgical punches, transferred into 96-well plates, and stored in
PBS. These gels were soaked in 10 μg/mL collagen 1 overnight (PureCol;
Advanced BioMatrix) before cell plating. Young’s moduli of the gels were
measured using AFM to be 1.1, 2.5, 4.2, 11.9, and 34.4 kPa for bisacrylamide
concentrations of 0.04, 0.1, 0.2, 0.5, and 1.3%, respectively; the Young’s
modulus scaled roughly linearly with cross-linker concentration (SI Text). SC
cells at passages 3–6 were seeded confluently (3 × 104 cells/cm2) on the gels,
grown in low-glucose DMEM with 1% FBS for 3 d, and switched to DMEM
with 1× ITS (Sigma-Aldrich) overnight before OMTC testing using PLL-coated
beads. After OMTC twisting, the cells were directly lysed in trizol (Life Technol-
ogies) and stored frozen until real-time quantitative PCR measurements as
described below.
Real-Time Quantitative RT-PCR. Structural integrity of RNA samples was con-
firmed by electrophoresis using 1% (wt/vol) agarose gels. First-strand cDNA
was prepared from total RNA using the iScript cDNA Synthesis Kit (Bio-Rad)
according to the manufacturer’s instructions. Real-time RT-PCR was per-
formed on a Bio-Rad iQ5 real-time PCR detection system (Bio-Rad) with the
temperature profile as follows: 40 cycles of 10 s melting at 95 °C, 40 s of
annealing and extension at 60 °C. All primer pairs (Invitrogen) (SI Text) ex-
tended over exon–intron boundaries. RNA that was not reverse-transcribed
served as negative control for real-time RT-PCR. To allow for relative quantifi-
cation, we identified housekeeping genes by using the software Genex (MultiD
Table 2. Summary of SC cell strain donor ages used in the
present study
Gene Cell strain no. Donor age, y
Normal SC41 64
SC51 66
SC52 71
SC58 34
SC60 58
SC61 88
SC67 44
SC68 30
SC71 44
Glaucoma SC57g 78
SC59g 55
SC62g 66
SC63g 78
SC64g 78
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Analysis) (39). In initial experiments, real-time RT-PCR for the potential
housekeeping genes GNB2L1, GAPDH, and RPL32 was performed for each of
the treatment protocols. Cycle threshold values were loaded to the software
that distinguishes genes that are regulated in a specific condition from those
that are very likely not. No differences were obtained between GAPDH and
GNB2L1, so GNB2L1was used for relative quantification of the real-time RT-PCR
experiments. Quantification was performed using Bio-Rad iQ5 standard edition
(Version 2.0.148.60623) software (Bio-Rad).
Statistical Methods. In general, the statistical analysis was done using SPSS
(version 12.0; IBM). Because the cell stiffness for each donor is approximately
log-normally distributed (SI Text), we reported it as median ± SE, which was
calculated based on logarithmically transformed data (34).
Regression analysis for the studies of the effect of substrate stiffness on
cell stiffness and gene expression used the following relationship:
VariableðESubstrateÞ
Variableð1:1  kPaÞ − 1= c1*

ESubstrate
1:1  kPa
− 1

+ c2*

ESubstrate
1:1  kPa
− 1

*Normal,
where VariableðESubstrateÞ is the value of the parameter being measured (cell
stiffness or gene expression) at a given value of substrate stiffness (Esubstrate).
Normal is 1 for normal cell strains and 0 for glaucomatous cell strains. Cor-
relations were taken as statistically significant when the correlation had an
overall significance of P < 0.01 and either substrate stiffness and/or glau-
coma affected the fit with P < 0.05 (unless otherwise noted). In all cases
where a statistically significant difference between glaucomatous cell strains
and normals was reported, the addition of donor age as an additional
covariate to the equation did not affect this conclusion (SI Text).
Because pore density is a discrete random variable comprising finite counts
of sparse events, Poisson statistics were applied and an E-test (40) was used to
compare Poisson-distributed pore densities between different perfusion
pressures and between normal and glaucomatous SC cell strains. The gen-
eralized linear model (GLM) was used for regression analysis of pore density
versus cell stiffness (as measured by AFM with a 10-μm spherical tip) applying
a logarithmic link function. Differences in porosity were analyzed using a
two-tailed two-sample Student t test. GLM analysis was also used for regression
analysis of porosity versus cell stiffness with an identity link function.
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Schlemm’s Canal Monolayer Perfusions and Pore Counting. Detailed
methods. Schlemm’s canal (SC) cells were seeded at confluence
and cultured for 2 d in serum-containing culture medium on the
external bottom-facing surface of a polystyrene filter mem-
brane insert (Corning Transwell 3470; 0.4-μm-diameter track-
etched pores), following previously described methods (1). The
filter membrane insert was sealed with a conical silicone stop-
per (Versilic; VWR) and the cells were perfused with serum-
free medium at 37 °C in a basal-to-apical direction at 0
(control), 2 or 6 mmHg. After 30 min, the cells were immersed
in fixative [2.5% (vol/vol) glutaraldehyde and 2.0% (wt/vol)
paraformaldehyde in PBS; TAAB Laboratories Equipment]
while perfusion with serum-free medium continued for an ad-
ditional 30 min. The perfusion was then stopped, and the
membrane insert was disconnected from the perfusion system
and immersed in fixative for an additional 30 min. Standard
procedures for scanning electron microscopy were used to ex-
amine the pores on a JSM 6390 scanning electron microscope
(JEOL). To determine whether pore formation depended on the
direction of perfusion, one SC cell strain (SC67) was perfused in
the reverse apical-to-basal direction. For these experiments, SC
cells were seeded on the internal top-facing surface of the filter
membrane, such that flow crossed the cell layer in the apical-
to-basal direction when the filter membrane insert was inter-
faced with the perfusion system.
Pore area and density (number of pores per square millimeter)
were quantified by sampling 12 randomly selected regions for
each cell layer. Each region (∼5,500 μm2) was imaged at 1,500×
magnification using scanning electron microscopy and any
pore-like feature was reimaged at 10,000× magnification. Pore
counting was done in a masked fashion. Pores were defined
as circular or elliptical openings through the cell layer with
smooth edges (2, 3). Pores were characterized as transcellular
(passing through an individual cell) or paracellular (intersect-
ing the junction between two neighboring cells) as previously
described (3).
Pore density. Transcellular and paracellular pore density increased
with perfusion pressure for all three nonglaucomatous cell strains
at 2 or 6 mmHg compared with unperfused controls at 0 mmHg
(P < 0.005; Fig. S1 A and B). When the pressure drop was re-
versed to perfuse one cell strain (SC67) in the apical-to-basal
direction at 6 mmHg, the paracellular pore density significantly
decreased compared with basal-to-apical perfusion (P < 10−6),
whereas the decrease in transcellular pore density was not sta-
tistically significant. The increased subcortical stiffness in glau-
comatous cell strains was significantly correlated with decreasing
transcellular pore density (P < 0.02; Fig S1C), with a borderline
significant correlation with decreasing paracellular pore density
(P < 0.07; Fig S1D).
Pore area. The porosity (total pore area per unit cell area) in-
creased significantly with perfusion pressure for all three normal
cell strains when perfused in the basal-to-apical direction at 2 (P<
0.019) or 6 mmHg (P < 0.004) but not in the apical-to-basal
direction at 6 mmHg (P = 0.79; SC67) relative to unperfused
controls (Fig. S2A). In the three glaucomatous cell strains, po-
rosity was markedly reduced compared with the three normal
cell strains when perfused at 6 mmHg in the basal-to-apical di-
rection (P < 0.035; Fig. S2B). The porosity seen in glaucomatous
SC cell strains perfused at 6 mmHg was comparable to that of
unperfused normal controls (Fig. S2 A and B).
For those two normal and three glaucomatous SC cell strains
in which both cell stiffness and pore area were measured, in-
creasing subcortical stiffness [measured by atomic force micros-
copy (AFM), 10-μm spherical tip] correlated with decreasing
porosity (P < 0.012; Fig. S2C).
AFM Studies. Control studies. The AFM data as measured with both
sharp and rounded tips were found to be non-Gaussian as de-
termined using Q-Q plots (4) (Fig. S3 A and B). However, a log
transformation of the data yielded a Gaussian distribution (Fig.
S3 C and D) and thus the statistics used on the AFM data were
done on log-transformed data.
Table S1 gives the P values (paired t test) for each tip geometry
when comparing the mean values at the nuclear versus non-
nuclear region for six normal and five glaucomatous strains. We
concluded that there were no significant differences between
AFM measurements in the nuclear and nonnuclear regions,
similar to a conclusion we had drawn earlier on other endo-
thelial cell types (5).
We investigated the possibility of a relationship between donor
age and modulus as measured by AFM using the Pearson cor-
relation coefficient. No such relationship was found (Table S2).
Thus, even though the glaucomatous cell strains come from
somewhat older individuals than do the normal cell strains, it is
not likely that this can explain the difference between the AFM
stiffnesses of normal and glaucomatous cells strains reported in
this study.
Effect of latrunculin-A. To examine the contribution of the actin
cytoskeleton to SC cell stiffness, normal and glaucomatous
SC cells were treated with the actin-depolymerizing agent
latrunculin-A, and then the cell stiffness was measured with
AFM using sharp tips and larger rounded tips. Treatment led
to complete depolymerization of the SC cell cortex and a very
substantial reduction in stress fibers and fibrillar collagen (Fig.
3A); there was no apparent difference in filamentous actin
distribution between normal and glaucomatous SC cells.
Latrunculin-A caused a significant decrease in cell stiffness of
both cortical and subcortical cytoskeleton in both normal and
glaucomatous SC cells (Fig. S4), confirming the importance
of actin to cell stiffness at both of these sites. There was no
apparent difference in the relative decrease in cell stiffness
caused by latrunculin-A when comparing normal to glaucoma-
tous cells.
Optical Magnetic Twisting Cytometry Studies. Effect of cell passaging.
We have previously evaluated the effect of cell passaging on the
mechanical phenotype of SC cells (6). Cell stiffness, contractile
response to FBS, and relaxing response to isoproterenol were
relatively stable from passages 2–6.
AFM characterization of gels.A commercial AFM (MFP-3D; Asylum)
was used with probes constructed with borosilicate spherical tips,
nominal diameter 5 μm, glued to triangular Au-coated silicon
nitride cantilevers with a nominal spring constant of 0.06
N/m (Novascan Technologies). Ten force-displacement curves
were collected from each sample and used to determine gel
modulus as a function of cross-linker concentration (Fig. S5).
Maximum forces were set to ∼1.5 nN.
Baseline studies.When SC cells were grown on a rigid substrate, we
did not find any difference in their baseline cytoskeletal stiffness
as measured using optical magnetic twisting cytometry (OMTC)
between normal and glaucomatous SC cells (Fig. S6).
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Effects of drugs that alter outflow resistance. We previously reported
how normal SC cells respond differently to drugs with known
effects on outflow resistance (6). Here we extend those results
to glaucomatous SC cells. Sphingosine-1-phosphate (S1P),
thrombin, and lysophosphatidic acid (LPA), all known to in-
crease outflow resistance at the tissue level, promptly increased
cell stiffness by up to 200% (Fig. S7). Conversely, latrunculin-A,
isoproterenol, dibutryl cyclic-AMP (DBcAMP), or Y-27632, all
known to decrease outflow resistance at the tissue level, dose-
dependently decreased cell stiffness by up to 80% (Figs. S7
and S8). In the case of isoproterenol treatment, the lack of
cytoskeletal softening correlated with the lack of β2 adren-
ergic receptor expression (Fig. S8G), consistent with our pre-
vious finding on normal SC cells alone (6). These results also
extended another previous finding—that drugs that modulate
outflow resistance also modulate SC cell stiffness in tandem (6)—
from normal to glaucomatous cells (i.e., glaucoma SC cells
are also responsive to treatments known to affect outflow re-
sistance).
Statistical methods for gene expression studies.The effect of cell strain
donor age was examined by adding this as an extra covariate to the
regression analysis:
VariableðESubstrateÞ
Variableð1:1  kPaÞ − 1= b1 p

ESubstrate
1:1  kPa
− 1

+ b2 p

ESubstrate
1:1  kPa
− 1

pNormal
+ b3 p

ESubstrate
1:1  kPa
− 1

pAge:
Only for three genes did this have any effect on the conclusions
from the regression analysis. MMP2 expression was found to de-
crease significantly with cell strain donor age (P < 0.001), to in-
crease with substrate stiffness (P < 10−4), and not to be affected by
glaucoma (P > 0.5). PAI1 was also found to decrease significantly
with cell strain donor age (P < 0.005), to increase with substrate
stiffness (P < 0.02), and not to be affected by glaucoma (P > 0.5).
The marginally significant negative association with substrate stiff-
ness in glaucomatous cells for PTGS2 was not distinguishable
from a marginally significant negative association with aging.
Real-Time Quantitative PCR. The sequences of primers used are
shown in Table S3.
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Fig. S1. Effects of pressure drop and subcortical stiffness on transcellular and paracellular pore density (number of pores per unit cell area). (A) Transcellular
pore density increases in nonglaucomatous SC cell strains when perfused in the basal-to-apical direction at 2 or 6 mmHg (P < 0.002) relative to unperfused
controls at 0 mmHg. (B) Paracellular pore density increases at 2 or 6 mmHg (P < 0.005) relative to 0 mmHg unperfused controls. Reversing the pressure drop in
one SC cell strain (SC67) decreased the paracellular (P < 10−6), but not transcellular, pore density. (C) There is a significant correlation (dark line) between decreasing
transcellular pore density and increasing subcortical Young’s modulus measured by AFM with 10-μm spherical tips (P < 0.02). (D) There is a borderline significant
correlation (dark line) between decreasing paracellular pore density and increasing subcortical Young’s modulus (P < 0.07). Bars represent SEM on pore density and
modulus. Light curves in C and D represent 95% confident intervals on the slope of the generalized linear model (GLM) linear regression.
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Fig. S2. Effects of pressure and glaucoma on porosity (pore area per unit cell area). (A) Porosity increases in three nonglaucomatous SC cell strains as
a function of pressure drop in the basal-to-apical direction at 0, 2, or 6 mmHg. In the one SC cell strain (SC67) perfused in the apical-to-basal direction (AB) at
6 mmHg, porosity is similar to the unperfused controls at 0 mmHg. (B) Porosity is less in glaucomatous (SC59g, SC62g, and SC63g) compared with normal SC cells
(SC52, SC 61, and SC67) following perfusion at 6 mmHg in the basal-to-apical direction. (C) There is a significant correlation (dark curve) between decreasing
porosity and increasing Young’s modulus as measured by AFM with 10-μm spherical tips. Bars represent SEM on porosity and modulus. Light curves in C
represent 95% confident intervals on the slope of the GLM linear regression.
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Fig. S3. Q-Q plots for AFM data. Plots compare the quantiles for the Young’s modulus measured to the expected values if data follow a normal distribution.
Left panels are for normal SC cells (SC41, SC51, SC52, SC58, SC60, and SC67); right panels are for glaucomatous SC cells (SC57, SC59, SC62, SC63, and SC64). (A)
AFM modulus measurements using sharp tips. (B) AFM data measurements with 4.5- and 10-μm spherical tips. (C) AFM measurements with sharp tips after
logarithmic transformation. (D) AFM data measurements with spherical tips after logarithmic transformation. All datasets follow a Gaussian distribution after
the transformation.
Fig. S4. Decrease in cell stiffness following latrunculin-A as measured by AFM. The ratio of the cell modulus measured after 30 min of treatment with la-
trunculin-A (1 μM) (Elatrunculin) compared with the cell modulus measured immediately before treatment with latrunculin (Ebaseline) in the same population of
cells. Measurements performed in two normal and three glaucomatous cell strains.
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Fig. S5. Effect of cross-linker concentration on the stiffness of gels, measured using AFM. Mean ± SEM, n = 10 per data point.
Fig. S6. Comparison of cell stiffness as measured by OMTC between normal and glaucomatous SC cells grown on rigid substrates. Cell stiffness (g) was
measured using OMTC with cells grown on collagen-coated plastic as described previously (6). Median ± SEM with n > 3,746 beads for each donor; P = 0.3 by
t test between normal (n = 7) and glaucoma strains (n = 5). Data for SC51, SC56, SC58, SC60, and SC61 were from our previous work (6) and are included here
for comparison.
Fig. S7. The evolution of cell stiffness with time was monitored using OMTC while the indicated drug was introduced at ∼50 s, as described previously (6).
Similar to normal SC cells (6), glaucomatous SC cells contracted in response to S1P (A), thrombin (B), and LPA (C) and relaxed in response to latrunculin-A (D).
Cell stiffness was normalized by predrug control. Median ± SEM with n > 300 beads for each data series. When we compared drug response at 300 s, there was
no difference between normal (n = 5) (6) and glaucoma (n = 5); P > 0.43.
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Fig. S8. The dose-dependent relaxation of SC cells was quantified using OMTC after ∼45-min incubation with the indicated drug, as described previously (6).
Similar to normal SC cells (6), glaucomatous cells also dose-dependently relaxed in response to Y-27632 (A), DBcAMP (B), and isoproterenol (C) in a donor-
dependent manner. Median ± SEM with n > 1,000 beads for each data point. When we compared drug response at each dose for each drug, there was no
difference between normal (n = 5) (6) and glaucoma (n = 5); P > 0.26. (D) The protein level of β2 adrenergic receptor was quantified using Western blot
(Upper); the protein of SC63 was run on another blot and not shown. Protein level was positively correlated with the relaxation response to 1 μM isoproterenol
(Lower). Data for normal SC cells were from our previous work (6) and are included here for comparison.
Table S1. Nucleus versus nonnuclear AFM measurements
AFM tip
P value for normal
lines (n = 6)
P value for glaucomatous
lines (n = 5)
Sharp 0.655 (m = 104) 0.071 (m = 148)
4.5-μm sphere 0.212 (m = 104) 0.928 (m = 122)
10-μm sphere 0.101 (m = 153) 0.735 (m = 111)
Paired t test, nucleus vs. cytoplasm. m, number of measurements.
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Table S2. Correlation coefficient (r) of AFM measurement with
donor age
AFM tip and cell strains r P value
4.5-μm sphere, all strains −0.02 0.960
Normals (n = 6, m = 104) −0.56 0.247
Glaucomas (n = 5, m = 128) −0.19 0.759
10-μm sphere, all strains 0.33 0.329
Normals (n = 6, m = 153) −0.28 0.590
Glaucomas (n = 5, m =120) 0.50 0.396
Sharp tip, all strains 0.39 0.235
Normals (n = 6, m = 104) 0.29 0.577
Glaucomas (n = 5, m = 148) 0.65 0.236
m, number of measurements; n, number of cells.
Table S3. Sequences of primers used for real-time RT-PCR
Gene Sequence Position
GAPDH 5′-AGCCACATCGCTCAGACA-3′ 83–148
5′-GCCCAATACGACCAAATCC-3′
GNB2L 5′-GCTACTACCCCGCAGTTCC-3′ 170–241
5′-CAGTTTCCACATGATGATGGTC-3′
MMP2 5′-ATAACCTGGATGCCGTCGT-3′ 2148–2210
5′-AGGCACCCTTGAAGAAGTAGC-3′
PAI1 5′-AAGGCACCTCTGAGAACTTCA-3′ 53–113
5′-CCCAGGACTAGGCAGGTG-3′
CTGF 5′-CTCCTGCAGGCTAGAGAAGC-3′ 884–977
5′-GATGCACTTTTTGCCCTTCTT-3′
COL1A1 5′-GGGATTCCCTGGACCTAAAG-3′ 1869–1928
5′-GGAACACCTCGCTCTCCA-3′
SPARC 5′-GTGCAGAGGAAACCGAAGAG-3′ 376–439
5′-TGTTTGCAGTGGTGGTTCTG-3′
TGM2 5′-GGCACCAAGTACCTGCTCA-3′ 1673–1742
5′-AGAGGATGCAAAGAGGAACG-3′
TPM1 5′-TGGATCAGACCTTGAAAGCA-3′ 790–880
5′-TCGGAAAGGACCTTGATCTC-3′
PTGS2 5′-TGGAAGCCTTCTCTAACCTC-3′ 512–613
5′-TCAGGAAGCTGCTTTTTACCTT-3′
ACTA2 5′-CTGTTCCAGCCATCCTTCAT-3′ 1262–1331
5′-TCAGGAAGCTGCTTTTTACCTT-3′
TGF-B2 5′-CCAAAGGGTACAATGCCAAC-3′ 1194–1283
5′-CAGATGCTTCTGGATTTATGGTATT-3′
DCN 5′-ATGCAGCTAGCCTGAAAGGA-3′ 1118–1199
5′-GAGCCATTGTCAACAGCAGA-3′
BMP4 5′-CTGCAACCGTTCAGAGGTC -3′ 225–315
5′-TGCTCGGGATGGCACTAC-3′
GREM1 5′-GTGACGGAGCGCAAATACC-3′ 406–509
5′-CCTTCCTCGTGGATGGTCT -3′
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